Currently, there are 267.31M common shares owned by the public and among those 258.31M shares have been available to trade.
The company’s stock has a 5-day price change of 18.52% and 108.75% over the past three months. AFRM shares are trading 35.43% year to date (YTD), with the 12-month market performance up to 160.27% higher. It has a 12-month low price of $22.25 and touched a high of $66.61 over the same period. AFRM has an average intraday trading volume of 11.69 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 26.43%, 41.94%, and 82.53% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Affirm Holdings Inc (NASDAQ: AFRM) shares accounts for 67.16% of the company’s 267.31M shares outstanding.
It has a market capitalization of $21.16B and a beta (3y monthly) value of 3.59. The earnings-per-share (ttm) stands at -$1.43. Price movements for the stock have been influenced by the stock’s volatility, which stands at 6.68% over the week and 7.36% over the month.
Earnings per share for the fiscal year are expected to increase by 66.82%, and 202.06% over the next financial year.
Looking at the support for the AFRM, a number of firms have released research notes about the stock. Wedbush stated their Neutral rating for the stock in a research note on October 14, 2024, with the firm’s price target at $45. Wells Fargo coverage for the Affirm Holdings Inc (AFRM) stock in a research note released on October 11, 2024 offered a Overweight rating with a price target of $52. Morgan Stanley was of a view on October 09, 2024 that the stock is Equal-Weight, while BTIG Research gave the stock Buy rating on October 08, 2024, issuing a price target of $68. Susquehanna on their part issued Positive rating on September 20, 2024.
